Supply Of INSULIN DEGLUDAC(r-DNA ORIGIN) 100 IU/ML(EQ. 3.66 MG) 3 ML FLEXPEN/ IN PFS/ PRE FILL PEN INJECTION. QUOTE ITS BRAND NAME FORMULATION LIFE PRODUCT IMAGE .
Tender Overview
Project Description
Supply Of insulin degludac(r-dna origin) 100 iu/ml(eq. 3.66 mg) 3 ml flexpen/ in pfs/ pre fill pen injection. quote its brand name formulation life product image . , insulin degludac(r-dna origin) 100 iu/ml(eq. 3.66 mg) 3 ml flexpen/ in pfs/ pre fill p en injection. quote its brand name formulation life product image . [ warranty period: 30 mon ths after the date of delivery ] [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ] , insulin degludac/ insulin aspart (1ml of solution contains 100 units of insulin d egludac 70% & 30% insulin aspart) in 3ml pfs/ pre fill pen/. quote its brand name formulation life and product image . [ warranty period: 30 months after the date of delivery ] [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
BOQ
| Sl. No. | Item Description |
|---|---|
| 1 | INSULIN DEGLUDAC(r-DNA ORIGIN) 100 IU/ML(EQ. 3.66 MG) 3 ML FLEXPEN/ IN PFS/ PRE FILL P EN INJECTION. QUOTE ITS BRAND NAME FORMULATION LIFE PRODUCT IMAGE . [ Warranty Period: 30 Mon ths after the date of delivery ] [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 lacs ] ] |
| 2 | INSULIN DEGLUDAC/ INSULIN ASPART (1ML OF SOLUTION CONTAINS 100 UNITS OF INSULIN D EGLUDAC 70% & 30% INSULIN ASPART) IN 3ML PFS/ PRE FILL PEN/. QUOTE ITS BRAND NAME FORMULATION LIFE AND PRODUCT IMAGE . [ Warranty Period: 30 Months after the date of delivery ] [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 lacs ] ] |
AI Tender Summary
Tender Timeline
Tender Published
Tender notice published.
CompletedBid Submission Deadline
Online submission via eProcurement portal.
Upcoming · 1 dayTender Documents
Download All (ZIP) ↓We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender